Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology
about
Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.Oral recombinant human or mouse lactoferrin reduces Mycobacterium tuberculosis TDM induced granulomatous lung pathology.Lactoferrin in a Context of Inflammation-Induced Pathology.Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.
P2860
Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@ast
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@en
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@nl
type
label
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@ast
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@en
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@nl
prefLabel
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@ast
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@en
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@nl
P2860
P921
P356
P1476
Lactoferrin: A Modulator for I ...... elated Granulomatous Pathology
@en
P2093
Jeffrey K Actor
P2860
P304
P356
10.1155/2015/409596
P407
P5008
P577
2015-12-14T00:00:00Z